Source: MarketScreener

LumiraDx: BioPharma Credit notes liquidity amendments to LumiraDX loan deal

(marketscreener.com) BioPharma Credit PLC on Tuesday said Lumira DX Investment Ltd announced an amendment on Monday to its loan agreement with BioPharma Credit, BioPharma Credit Investments V LP and BPCR Ltd Partnership. Specialist life sciences debt investment trust BioPharma Credit noted the loan agreement was dated March 2021 with itself as collateral agent and...https://www.marketscreener.com/quote/stock/BIOPHARMA-CREDIT-PLC-34413398/news/BioPharma-Credit-notes-liquidity-amendments-to-LumiraDX-loan-deal-44875111/?utm_medium=RSS&utm_content=20230919

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Ron Zwanziger's photo - Chairman & CEO of LumiraDx

Chairman & CEO

Ron Zwanziger

CEO Approval Rating

88/100

Read more